ADMA BIOLOGICS, INC. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Adma Biologics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q3 2024.
- Adma Biologics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $1.9M, unchanged year-over-year.
- Adma Biologics, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $7.6M, a 1.33% increase year-over-year.
- Adma Biologics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $7.6M, a 18.8% increase from 2022.
- Adma Biologics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $6.4M, a 33.3% increase from 2021.
- Adma Biologics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $4.8M, a 50% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)